Paper Chase is a research database designed to offer abstracts of research articles published in journals that have a highly rated impact factor as determined by ISI Impact Factor and PageRank. Abstracts are organized by date, with the most recently published papers listed first. 

Paper Chase

22.

Everolimus for the treatment of advanced, non-functional neuroendocrine tumours of the lung or gastrointestinal tract (RADIANT-4): a randomised, placebo-controlled, phase 3 study.

Lancet.
Yao JC, Fazio N, Singh S, Buzzoni R, Carnaghi C, Wolin E, Tomasek J, Raderer M, Lahner H, Voi M, Pacaud LB, Rouyrre N, Sachs C, Valle JW, Fave GD, Van Cutsem E, Tesselaar M, Shimada Y, Oh DY, Strosberg J, Kulke MH, Pavel ME.
| Dec 15, 2015
23.

Ezh2 regulates differentiation and function of natural killer cells through histone methyltransferase activity.

Proc. Natl. Acad. Sci. U.S.A.
Yin J, Leavenworth JW, Li Y, Luo Q, Xie H, Liu X, Huang S, Yan H, Fu Z, Zhang LY, Zhang L, Hao J, Wu X, Deng X, Roberts CW, Orkin SH, Cantor H, Wang X.
| Dec 29, 2015
24.

Identification of focally amplified lineage-specific super-enhancers in human epithelial cancers.

Nat. Genet.
Zhang X, Choi PS, Francis JM, Imielinski M, Watanabe H, Cherniack AD, Meyerson M.
| 12 14, 2015
25.

Acalabrutinib (ACP-196) in Relapsed Chronic Lymphocytic Leukemia.

N. Engl. J. Med.
Byrd JC, Harrington B, O'Brien S, Jones JA, Schuh A, Devereux S, Chaves J, Wierda WG, Awan FT, Brown JR, Hillmen P, Stephens DM, Ghia P, Barrientos JC, Pagel JM, Woyach J, Johnson D, Huang J, Wang X, Kaptein A, Lannutti BJ, Covey T, Fardis M, McGreivy J, Hamdy A, Rothbaum W, Izumi R, Diacovo TG, Johnson AJ, Furman RR.
| Jan 28, 2016
26.

Targeting BCL2 with Venetoclax in Relapsed Chronic Lymphocytic Leukemia.

N. Engl. J. Med.
Roberts AW, Davids MS, Pagel JM, Kahl BS, Puvvada SD, Gerecitano JF, Kipps TJ, Anderson MA, Brown JR, Gressick L, Wong S, Dunbar M, Zhu M, Desai MB, Cerri E, Heitner Enschede S, Humerickhouse RA, Wierda WG, Seymour JF.
| Jan 28, 2016
27.

Peptidic degron in EID1 is recognized by an SCF E3 ligase complex containing the orphan F-box protein FBXO21.

Proc. Natl. Acad. Sci. U.S.A.
Zhang C, Li X, Adelmant G, Dobbins J, Geisen C, Oser MG, Wucherpfenning KW, Marto JA, Kaelin WG.
| Dec 15, 2015
28.

High-Resolution CRISPR Screens Reveal Fitness Genes and Genotype-Specific Cancer Liabilities.

Cell.
Hart T, Chandrashekhar M, Aregger M, Steinhart Z, Brown KR, MacLeod G, Mis M, Zimmermann M, Fradet-Turcotte A, Sun S, Mero P, Dirks P, Sidhu S, Roth FP, Rissland OS, Durocher D, Angers S, Moffat J.
| Dec 3, 2015
30.

Sequence-Intrinsic Mechanisms that Target AID Mutational Outcomes on Antibody Genes.

Cell.
Yeap LS, Hwang JK, Du Z, Meyers RM, Meng FL, Jakubauskaitė A, Liu M, Mani V, Neuberg D, Kepler TB, Wang JH, Alt FW.
| Nov 19, 2015
31.

Advanced neuroendocrine prostate tumors regress to stemness.

Proc. Natl. Acad. Sci. U.S.A.
Ellis L, Loda M.
| Nov 24, 2015
32.

Role of vascular density and normalization in response to neoadjuvant bevacizumab and chemotherapy in breast cancer patients.

Proc. Natl. Acad. Sci. U.S.A.
Tolaney SM, Boucher Y, Duda DG, Martin JD, Seano G, Ancukiewicz M, Barry WT, Goel S, Lahdenrata J, Isakoff SJ, Yeh ED, Jain SR, Golshan M, Brock J, Snuderl M, Winer EP, Krop IE, Jain RK.
| Nov 17, 2015
33.

Prostate-Specific Antigen Screening After 2012 US Preventive Services Task Force Recommendations.

JAMA.
Sammon JD, Abdollah F, Choueiri TK, Kantoff PW, Nguyen PL, Menon M, Trinh QD.
| Nov 17, 2015
34.

Evaluating an Elevated Screening PSA Test.

JAMA.
Barry MJ, Hayes JH.
| Nov 17, 2015
35.

Genetic predisposition to neuroblastoma mediated by a LMO1 super-enhancer polymorphism.

Nature.
Oldridge DA, Wood AC, Weichert-Leahey N, Crimmins I, Sussman R, Winter C, McDaniel LD, Diamond M, Hart LS, Zhu S, Durbin AD, Abraham BJ, Anders L, Tian L, Zhang S, Wei JS, Khan J, Bramlett K, Rahman N, Capasso M, Iolascon A, Gerhard DS, Guidry Auvil JM, Young RA, Hakonarson H, Diskin SJ, Look AT, Maris JM.
| Dec 17, 2015
36.

SWI/SNF-mutant cancers depend on catalytic and non-catalytic activity of EZH2.

Nat. Med.
Kim KH, Kim W, Howard TP, Vazquez F, Tsherniak A, Wu JN, Wang W, Haswell JR, Walensky LD, Hahn WC, Orkin SH, Roberts CW.
| 11 09, 2015
37.

A SARS-like cluster of circulating bat coronaviruses shows potential for human emergence.

Nat. Med.
Menachery VD, Yount BL, Debbink K, Agnihothram S, Gralinski LE, Plante JA, Graham RL, Scobey T, Ge XY, Donaldson EF, Randell SH, Lanzavecchia A, Marasco WA, Shi ZL, Baric RS.
| 11 09, 2015
38.

TERT rearrangements are frequent in neuroblastoma and identify aggressive tumors.

Nat. Genet.
Valentijn LJ, Koster J, Zwijnenburg DA, Hasselt NE, van Sluis P, Volckmann R, van Noesel MM, George RE, Tytgat GA, Molenaar JJ, Versteeg R.
| 11 02, 2015
39.

Gate control of mechanical itch by a subpopulation of spinal cord interneurons.

Science.
Bourane S, Duan B, Koch SC, Dalet A, Britz O, Garcia-Campmany L, Kim E, Cheng L, Ghosh A, Ma Q, Goulding M.
| Oct 30, 2015
40.

Foreign DNA capture during CRISPR-Cas adaptive immunity.

Nature.
Nuñez JK, Harrington LB, Kranzusch PJ, Engelman AN, Doudna JA.
| Nov 26, 2015